Mostrando entradas con la etiqueta Competencia. Mostrar todas las entradas
Mostrando entradas con la etiqueta Competencia. Mostrar todas las entradas

sábado, 1 de noviembre de 2014

IGEM Giant Jamboree 2014


More than just a competition! 
The iGEM competition encourages university student researchers to work in teams and solve real-world challenges by building genetically engineered biological systems with standard, interchangeable parts called BioBricks from the Registry of Standard Biological Parts. Each team manages their own projects, advocates for their research, and secures funding. Teams are also challenged to actively consider and address the safety, security and environmental implications of their work.

In celebration of iGEM’s 10-year anniversary this year, we are doing things a bit differently.
Unlink previous year’s competition two tiered structure, this year ALL participants advance to compete in Boston,MA. With no regionals, all participants are invited to the Giant Jamboree to present their accomplishments and compete in front of a global audience.

Come join the fun and share in the excitement as teams showcase their work in Synthetic Biology.

The Giant Jamboree is organized by the iGEM Foundation

GIANT JAMBOREE
The iGEM competition encourages University student researchers to work in teams and attempted to solve real-world challenges by building genetically engineered biological systems with standard, interchangeable parts called BioBricks from the Registry of Standard Biological Parts. Each team manages their own projects, advocates for their research, and secures funding. Teams are also challenged to actively consider and address the safety, security and environmental implications of their work.

In celebration of iGEM’s 10-year anniversary this year, we are doing things a bit differently.

Unlink previous year’s competition two tiered structure, this year ALL participants advance to compete in Boston, MA. With no regionals, all participants are invited to the Giant Jamboree to present their accomplishments and compete in front of a global audience.

Come join the fun and share in the excitement as teams showcase their work in Synthetic Biology.


iGEM Foundation
The International Genetically Engineered Machine (iGEM) Foundation is dedicated to education and competition, advancement of synthetic biology, and the development of open community and collaboration. In 2012, iGEM spun out of MIT and became an independent nonprofit organization located in Cambridge, Massachusetts, USA. The iGEM Foundation fosters scientific research and education through organizing and operating the iGEM Competition, the premier student synthetic biology competition.

It also fosters scientific research and education by establishing and operating the Registry of Standard Biological Parts, a community collection of biological components. The organization promotes the advancement of science and education by developing an open community of students and practitioners in schools, laboratories, research institutes, and industry. The iGEM community has a long history of involving students and the public in the development of the new field of synthetic biology.

Visit iGEM.org for more information

ORIGINAL: IGEM

viernes, 20 de diciembre de 2013

Costa Rica gana la Magna Competencia Internacional de Ciencias y Matemáticas

Juan Carlos Badilla Rojas, representante de Costa Rica, fue el ganador de la 6ª. Edición de La Magna Competencia Internacional de Ciencias y Matemáticas de Operación Éxito en una final contra el representante de Chile, Fernando José Figueroa Zamora, haciendo que este país centroamericano ganara por primera vez esta competencia hemisférica.

De izquierda a derecha, el Secretario General de Virtual Educa, José María Antón, el Secretario de Educación de Puerto Rico, Rafael Román, Juan Carlos, y el creador de OE, Noel Quiñones
Juan Carlos Badilla Rojas, representante de Costa Rica, fue el ganador de la 6ª. Edición de La Magna Competencia Internacional de Ciencias y Matemáticas de Operación Éxito en una final contra el representante de Chile, Fernando José Figueroa Zamora, haciendo que este país centroamericano ganara por primera vez esta competencia hemisférica.

Este año los estudiantes demostraron uno de los niveles más altos que se habían visto en La Magna y provenían de Argentina, Chile, Perú, Colombia, Panamá, Costa Rica, Estados Unidos, España y Puerto Rico con edades que oscilaban entre los 16 y los 18 años, y solo dos féminas, las representantes de Estados Unidos y Colombia.

En la primera eliminatoria y después de dos rondas de preguntas, quedaron eliminados Estados Unidos, Puerto Rico, Argentina, Medellín, Virtual Educa, Panamá y España, pasando Antioquia, Chile, Perú y Costa Rica.

Fue en la segunda eliminatoria y tras dos rondas de puntuaciones que casi alcanzaban la perfección, cuando Juan Carlos de Costa Rica y Fernando de Chile pasaban a competir en la mencionada final.

La sorpresa sobrevino cuando el ganador tomaba el micrófono y en presencia de todos sus compañeros anunciaba que por común acuerdo iban a repartir el dinero de la beca entre todos ellos, algo que nunca había ocurrido y que demuestra la extrema generosidad de los corazones de estos muchachos. El ganador además ganó un viaje al Cañón del Colorado, al tiempo que el Presidente de la Universidad de Puerto Rico, Urayoán Walker anunciaba una beca completa por cuatro años para el ganador.

Con una asistencia que sobrepasaba las 800 invitados provenientes de todo Puerto Rico y de diferentes países de la América total, la competencia estuvo presidida por el Presidente del Senado, Hon. Eduardo Bathia, el Secretario de Educación, Prof. Rafael Román, el Secretario General de Virtual Educa, José María Antón, Noel Quiñones, creador de Operación Éxito, y cerraba el evento el Secretario de Estado, Hon. David Bernier, quien hizo especial mención a la necesidad de adaptar los sistemas educativos a las formas y maneras en que la juventud se mueve y respira: la tecnología, ”cambio que han sabido hacer Noel y Soraya con Operación Éxito”.

El evento, llevado a cabo en el Centro de Convenciones de Puerto Rico, fue el cierre del congreso, Virtual Educa La Magna, que por tres días reunió en la Isla a unos 3,000 educadores, maestros, representantes de universidades y políticos de todo el continente para hablar y discutir sobre alternativas y soluciones a los nuevos retos que están planteando la sociedad en general, y las nuevas generaciones en particular, a la Educación del siglo XXI.

Ya no podemos hablar de la responsabilidad del maestro únicamente porque problemas como la deserción escolar son situaciones que involucran a la misma escuela, los padres y la comunidad adyacente al plantel como hemos podido demostrar en el programa Uno a Uno que Operación Éxito probó exitosamente en Aguadilla y que logró que se graduara el 95% de los estudiantes que iban a fracasar; es por eso que con esta competencia y la beca de $100,000 dólares queremos mostrar que existen soluciones a los problemas de la Educación de nuestro hemisferio”, señalaba Noel Quiñones, Presidente de Virtual Educa Las Américas y creador de Operación Éxito.

Este año entre los estudiantes que compitieron los había fanáticos de las Matemáticas (Juan Ignacio Agudelo de Medellín), otros que se entretenían armando una y otra vez el cubo Rubick (Fernando José Figueroa de Chile), los había lectores fanáticos de libros de Filosofía (Carlos Verga de España), músicos que tocan el órgano eléctrico (Jesús Eladio Montalvo de Perú) o quién hace solo dos años estaba en otro país (Vy Vu de Estados Unidos y que proviene de Vietnam), pero todos ellos eran muchachos que aspiraban a poner el nombre de su país en alto.

Los 11 participantes han estado estos días recorriendo Puerto Rico en una serie de aventuras científicas que incluyeron visitas al observatorio de Arecibo, a las cavernas del río Camuy y a un laboratorio de biología marina de la UPR, Recinto de Mayagüez, entre otras, con el fin de adquirir nuevas experiencias y fomentar un espíritu de grupo y de amistad entre ellos.

Hasta ahora, La Magna Competencia Internacional de Ciencias y Matemáticas había sido ganada por estudiantes de 
  • Puerto Rico (Melanie Santos 2008 y Dérek García 2012), 
  • Colombia (Rubén Darío Sarmiento 2009) y 
  • España (Pablo Pérez 2010 y María de los Ángeles Pla 2011), 
muchachos todos ellos de una excelente preparación y quienes viajan a Puerto Rico acompañados de algunos de sus familiares y/o sus maestros.

redacción de OE Blog - 
18/12/2013

domingo, 9 de junio de 2013

Interview: Dan Perez, Founder and CEO of Marblar

04 June 2013

Interview: Dan Perez, Founder and CEO of Marblar
Dan Perez
LONDON: Today, 16% of all waste generated by the global society, 31% of all energy consumed and 10% of all fresh water used, is consumed in and around our homes. The EarthHack, conceived by UK start-up Marblar in partnership with The Climate Group, is an international competition which invites competitors from all disciplines to re-imagine existing technology to address this fact by creating a more sustainable home.

Supported by leading retailers Phillips and IKEA, the first prize winner of the EarthHack will take home $15,000, with a shared pot of $25,000.

The Climate Group’s Alana Ryan spoke with Dan Perez about the origins of Marblar, the potential crowdsourcing offers and how the EarthHack can revolutionize energy consumption and waste management within the home.

For those who aren’t familiar with Marblar, could you briefly explain what it is and how it came about?
Marblar crowdsources market applications for emerging and existing technology. We work with universities, research institutes and technology companies to post interesting technology in the form of a challenge, asking people: “what would you do with this technology?” We have a community of creatives from around the world who compete and collaborate towards re-imagining existing technology into new applications.

I am a PhD student in biochemistry, and so I saw first-hand a load of technology that wasn’t being commercialized (like less than 95%) and that seemed like a terrible waste. Moreover, there is latent genius everywhere – so our premise was borne: allowing people from across disciplines and around the world to chew on technology from a variety of angles.

A novel feature of Marblar is the emphasis that it places on crowdsourcing. Do you see crowdsourcing as the future of technological progress?

As science has progressed, we’ve increasingly become specialized – to the point where today’s scientists may not fully appreciate how their discoveries may fit into other disciplines, or how other disciplines can add to their inventions. With Marblar we breakdown science such that non-experts could understand, with the aim of re-establishing perspective.

Obviously a stem-cell biologist isn’t much of a laser physicist, but that biologist might understand enough about the laser to think: “why not point this at stem cells?” Something the physicist may not have even considered. Those are the types of serendipitous interactions we’re looking to spark.

What led you to develop the EarthHack competition, and how specifically can it help tackle climate change?
The EarthHack was very much something that was conceived jointly with Ben Ferrari and Mark Kenber at The Climate Group. Our initial conversations were about our two platforms and how we could leverage challenge-driven innovation to not just realize potential in existing technologies, but to focus that potential towards carbon reducing solutions.

The EarthHack was a result of that incredible collaboration and brainstorming, and we’re absolutely thrilled by its progress and the potential for more EarthHacks.

For a small start-up how important is it to have partners such as IKEA, Philips and The Climate Group for achieving global reach?
As a small start-up it’s not always easy to be taken seriously by large corporates – especially given their portfolio and the many opportunities coming their way from more established companies. For Marblar, what really helped was working with a more established organization, like The Climate Group. While older and well respected, the charity is very nimble and flat, and has the ear of multi-nationals.

I’d encourage start-ups to think about these peripheral avenues to tap into, consider having larger companies, NGOs, universities or wealthy individuals on your advisory board.

Who can actually enter the EarthHack?
Anyone can enter the EarthHack! Ok ok, well, you have to be over 18. But aside from that, the competition is open to anyone from around the world, and we hope to realize concepts and solutions for not just Western homes, but to re-imagine sustainable homes globally.

Do you have any plans for further sustainability orientated competitions? Absolutely, we’re already in the preparation phase of EarthHack’s for transport, information technology/communications, and perhaps even biomimetics. Stay tuned!

Read more:

lunes, 29 de abril de 2013

OneStart Top 10 Announced!

ORIGINAL: Oxbridge Biotech
JohnDaley
21st April 2013

OBR and SR-One are pleased to announce the Top 10 teams in the OneStart Competition. After extensive work with their industry mentors, all 35 semi-finalist teams developed comprehensive pitches and business plans. The judges, after poring over the submissions, have chosen only 10 to move on to the final round. These teams will present their ideas at the Finals Gala on May 16th, where one will walk away with the £100K prize!



1) anywhereHPLC
anywhereHPLC is a novel analytical platform developed by researchers at the Institute of Chemical Biology at Imperial College in London, allowing precise and reproducible measurement of small-molecule metabolites at the point of sampling – in the field or the home. anywhereHPLC will provide rapid diagnoses and disease monitoring in many environments where no alternative tool exists, ranging from applications in the developing world to the patient-led supervision of chronic diseases in Europe and the USA. anywhereHPLC can deliver instant results when and where they are needed, providing the diagnostic power of gold-standard laboratory equipment from an integrated, disposable unit with a foot-print smaller than a paperback book.

2) BioAmp
The cost of healthcare is rising unsustainably across the globe. Remote health monitoring has exceptional potential to both reduce the financial burden of healthcare, reducing the number of patient visits to medical centres, and improve treatment outcomes through closer monitoring. BioAmp Diagnostics is a startup exploiting highly innovative new technology developed by the founders at the University of Cambridge. Our patent filed technology has significant advantage for use in remote health monitoring over current diagnostic technologies in its small form factor, extremely low power, multiplexing potential (hence adding accuracy to clinical decisions) and integrability with existing electronic infrastructure such as smartphones for efficient data transfer. We are initially targeting lucrative segments within the chronic and acute cardiac disease market, where our technology aids clinical decisions and adds significant value to healthcare providers. The BioAmp team combines expertise in electronic engineering, nanotechnology, informatics, biology and business development. Our complimentary backgrounds form an excellent foundation to propel this powerful new technology forward to market.

3) FoetoH
FoetoH is a novel portable technology for pregnant mothers to monitor the health of their babies themselves, at hospital level accuracy, in the comfort of their own homes. Mothers would use the device by strapping on FoetoH’s sensor belt and launching its smartphone application. FoetoH acquires and analyses foetal heart rate signals according to clinical guidelines using a combination of wireless ultrasound and sophisticated signal processing. It then presents mothers with information on the health of their baby in real time in an easy to understand colour coded manner. FoetoH also provides the mother with information on what to do next, and allows her to transfer the results to her physician. The product aims to provide reassurance to pregnant mothers in moments of uncertainty and empower them to be more actively involved in promoting the health of their babies, while simultaneously contributing to preventing stillbirths and neonatal deaths – 11 of these occur globally each minute. The company, F-GHS, is headquartered in London, UK. The current management consists of co-founders and Oxford PhDs, Michelle Fernandes and Ricardo Pachόn. Michelle is a clinician with expertise in foetal development, and antenatal monitoring. Ricardo is a mathematician with 10+ years of experience in pattern recognition automation. The management is supported by three advisory committees, consisting of medical, technical and business experts.

4) Hackett Biologics
Hackett Biologics was formally founded in 2009 and has primarily focused on designing and developing novel materials including injectables, patches, conduits and scaffolds. All research and therapies involving stem cells rely on a ‘cold chain’ for storage and distribution, thus introducing loss of efficacy, viability, chemical contaminants, logistical issues and costs. Hackett Biologics has developed a proprietary technology that stabilises stem cells at room temperature, removing the need for freezing; as such a significant market opportunity exists for the technology. Dr. Joanne M. Hackett, CSO and Founder, has a background in regenerative medicine and tissue engineering. She has been an assistant professor of regenerative medicine at Linköping University in Sweden, a visiting scientist/strategy lead at Pfizer Neusentis and Director of Business Development for Bodymetrics. She is currently the strategic & commercial partnerships executive at the Royal Society of Chemistry. Dr. Ryan B. MacDonald, Project Manager/scientific advisor has been critically involved in Hackett Biologics since its inception in 2009. He has a background in stem cell biology, principally studying the differentiation and proliferation of neural stem cells. He is currently a Herchel Smith Research Fellow at the University of Cambridge, a research associate at Clare College and an Associate Fellow of the Higher Education Academy.

5) LipoPep
LipoPep is a targeted drug delivery system that allows for existing therapeutics to be actively and selectively delivered to the placenta, providing the first treatment option for pregnancy complications. Placental abnormalities affect approximately 10% of pregnancies worldwide and cost in excess of $(US) 40 billion per year. Such abnormalities lead to pre-eclampsia and fetal growth restriction, which result in an increased risk of stillbirth, premature birth, neonatal death and poor health in adulthood. Currently there is no therapeutic intervention for these complications, with the only treatment option being premature delivery. LipoPep is being taken through pre-clinical development by Dr Lynda Harris, a BBSRC David Phillips Research Fellow, and Anna King and Natalie Cureton who both undertaking PhDs in nanoscience. Development is fully supported by the School of Pharmacy and the Maternal and Fetal Health Research Centre in St Mary’s Hospital, at The University of Manchester.

6) MPDx
MPDx Technologies, founded in 2012 and based in Cambridge, UK, is developing portable, automated sample processing technology as an enabler for truly integrated sample-to-result diagnostics. MPDx´s innovative, yet proven, robust sample extraction platform will address the urgent unmet clinical need for early diagnosis within high value and rapidly growing infectious disease diagnostic markets, to deliver step-change benefits to consumers and have a profound impact on patient lives. MPDx´s passionate, interdisciplinary team of technical, business and finance professionals comprises a wealth of complementary industry-specific expertise to ensure success of the business.

7) Picoto
The cornerstone of healthy living is a healthy beginning. Yet 80% of the globe does not have this guarantee — vulnerable babies begin their lives everyday. Picoto is our solution for newborns worldwide. It is a complete, networked system of intelligent sensors and algorithms that monitor neonatal health parameters — and empower actionable healthcare delivery to provide a neo-standard of care. Picoto is being developed by a group of dedicated, multidisciplinary researchers at the University of Oxford.

8) Puridify
Puridify ltd. is a London based spinout company from the Department of Biochemical Engineering, University College London. Our flagship product, FibroSelect, is a new chromatography reagent structure that utilises existing purification chemistries in a more efficient manner. The result is a significant reduction in biotherapeutic manufacturing costs (c.25%) addressing the global demand for cheaper drugs and widening patient access to new and existing therapeutics.

9) Pym
James Flewellen and Irwin Zaid are postdoctoral research fellows in the Department of Physics at the University of Oxford. We aim to develop a mobile diagnostic platform based on a novel form of microscopy. Most microscopic diagnoses are performed by highly-trained staff in dedicated medical laboratories looking at samples through a microscope. Our idea will automate much of this analysis and allow a health practitioner anywhere to perform a fast and cost-effective optical diagnosis of a fluid sample. Our plan involves developing a portable imaging device that attaches to your smartphone. The smartphone camera is used to form images of a fluid sample, which are uploaded to a cloud server for processing and analysis. Unlike conventional microscopy, we are able to capture 3D position and shape data of particles suspended in the sample. This data is then analysed by server-side software returning a diagnosis to the practitioner. Our first application is urinary tract infections, which are currently diagnosed by seeing bacteria in a urine sample – something our software can detect automatically.

10) Tecrea
Stem cell therapy offers a promising potential to cure many clinical conditions such as spinal cord injury, stroke, amyotrophic lateral sclerosis, macular degeneration, Parkinson’s disease, Type I Diabetes etc. Any cell can be re-programmed via the introduction of genes, proteins and small molecules to provide induced pluripotent stem cells (iPSC), which are of huge interest for therapy and are also valuable in drug discovery research and toxicology. Cell reprograming, however, is greatly limited by poor gene or protein delivery efficiencies. Current delivery strategies are too toxic and difficult to translate into the clinic for therapeutic applications.Tecrea-stem has a novel nanotechnology-based delivery platform for biomolecules (DNA, RNA, protein and small molecule). The platform is clinically safe and protected by a pending patent. This technology utilises an existing polymer that has been used safely for 50 years. Our discovery shows that this polymer forms nanoparticles with a wide range of cargo molecules and delivers them efficiently into eukaryotic cells with minimal stress. We have extensive lab-based evidence demonstrating how our technology works. We propose that our nano-polymer can be optimised for efficient stem cell reprogramming, which will facilitate the advancement of stem cell research and therapy.


This post was written by:JohnDaley

jueves, 7 de febrero de 2013

MIT Builds An Open-Source Platform For Your Body

ORIGINAL: FastCo
FEBRUARY 5, 2013


About This Series

Meet the people and discover the personalities driving the world's most radical, disruptive, and creative companies.READ MORE
MIT Media Lab's 11-day health care hackathon pulled students and big companies together with a common goal: Healing a broken industry.

Hack Thyself. The goal of the annual MIT Health and Wellness Hackathon is to jump-start an open source platform where apps that track all different aspects of your bodily health can exchange information. Here are this year's projects from the MIT Media Lab's 11-day event.
Siberian temperatures. Eleven grueling days, navigating rough terrain. Six teams, matched for talent, competing for glory at the end. The Iditarod? Nah, just the annual MIT Health and Wellness Hackathon.

This isn’t your average social app-fest. The goal is to jump-start an open source platform where apps that track all different aspects of your bodily health can exchange information. It’s a Sisyphean task, since most digital health solutions today are trapped in silos, but the organizers believe they can change that by enfranchising big companies instead of trying to disrupt them.

Healing The Health Industry
The tradition in health care technology is, ‘This is our device, we make our own software,’” says Dr. John Moore, who organized the hackathon. “The goal is to connect that bit of knowledge to the rest of your health experience. Just keeping track of your step count, for example, won’t let you change the rest of your life.”"JUST KEEPING TRACK OF YOUR STEP COUNT, FOR EXAMPLE, WON’T LET YOU CHANGE THE REST OF YOUR LIFE.

To unify the segmented market for health technology takes heavy lifting on the engineering side, since much of the progress made by private companies hasn’t been shared back to the community. Here, each team is required to use open source and open standard tools so that things work together seamlessly: specifically, the Lab's patient-centered CollaboRhythm platform and the Indivo X system for personalized health records.

Working from a common platform takes an extra effort to build,” Moore says, “but it ensures that the prototype will be something that has legs.” With Boomers aging and a lack of innovation coming from industry, the upside for these projects could be huge--but undertaking them is intimidating. “We thought we’d have to reject people,” says Moore, “but instead we just scared them off.

Hacking Together Industry Partnerships
The teams encamped on the Media Lab’s sixth floor, overlooking a Charles River initially frozen so solid you could stroll over to the Back Bay for pizza. This is the fourth such hackathon sponsored by the Lab’s New Media Medicine research group; when it started, the competition was 20 mostly MIT students who spent their winter break experimenting with open source innovation platforms for health care. Now the group includes an international assembly of professors, doctors, graduate and undergraduate students, as well as engineers from MIT sponsor companies like MIT sponsor companies like ViiV, Humana, Motorola and Fleury. Still, it’s only a start.

The hackathon itself is not enough to produce change, but it's an opportunity to expose important players in the ecosystem--pharma, insurers, medical diagnostics companies, startup entrepreneurs, consumer electronics companies--to the value of using and contributing to these platforms,” says Moore. “It’s rare to get these players to converge, but these 80 people are influencers, and now they know each other so they can collaborate. Big innovations will come when they all see how they can benefit each other.”

Matched into six project teams before arriving in Cambridge, the groups come at problems from different interests and areas of expertise, then work to create solutions that are more than just one-off apps or devices.

It would take years for all of these sectors to realize the potential that they have seen unfolding in the two weeks of this event,” says Moore. “It is this seed that may lead them to build their products differently and encourage that to collaborate with partners from other sectors using the same tools.

How Do You Incentivize Product-Ready Hacks?
The focus here is on producing commercially viable products. “Suddenly, you [can] have a really well-rounded tool that can be at the level of sophistication where you can get funding for a startup or a research grant,” says Moore. "We make sure the business people are supportive, and not just looking at today's business models.... We squash negativity. That's a big problem in the health space, where innovative ideas are often killed with comments like, 'Nah, nobody will ever get paid for that.' I act as the benevolent dictator to enforce that.""WE SQUASH NEGATIVITY. THAT'S A BIG PROBLEM IN THE HEALTH SPACE."

At the Health and Wellness hackathon, the winners aren't rewarded with cash since winning is only the beginning. Kaiser Permanente donated $15,000 to support the teams during development, instead of forcing them to go out-of-pocket to build their hacks. Awarding money to participants helps unshackle some of the crazier ideas; because current medical systems are plagued with legacy software, Moore wants participants to think blue-sky without being too constrained by cost. “We’re looking for optimal solutions,” Moore says, “more 'greenfield' kind of ideas." (Read on for examples from this year's projects.)

The Lab also provides on-site mentors in the form of software developers, professional UI designers, and video teams to bring projects to fruition. A team member with business experience is attached to each group, but is forbidden from dismissing good ideas that may be promising, but don't have a traditional revenue stream.

By the end of the marathon event, the Charles had thawed, and signs of encouragement were everywhere inside as well, says Frank Moss, a health care entrepreneur and former MIT Media Lab director. Driven by demands from patients and clinicians, he says everyone from the White House to the business community is “saying things we were saying four years ago,” around the time of the inaugural Health and Wellness hackathon. Here’s wishing the industry a speedy recovery.

The Projects
Last year’s Health and Wellness Hackathon winners, dubbed the Chameleon team, went on to launch a company called GeckoCap which produces a device for tracking asthma inhaler usage. The company, which was named “One of the Best Gadgets of CES 2013,” is currently raising funds on Indiegogo

Here are some of this year’s entrants.

hiVIVA

Adherence to medications is the key to keeping HIV/AIDS patients healthy, but compliance can be a problem. This app uses gaming to encourage users to take their pills. Users begin by uploading a photo they love to the home screen on their cellphone. Each morning, that image starts out fuzzy; the goal of the game is to sharpen it over the course of the day, based on adherence to the patient’s medication schedule. The system also gives patients a “virtual pill box” containing images of the actual pills in their regimen, to avoid confusion. Data is simultaneously sent to the patient’s physician via Bluetooth, and an accompanying device will eventually allow a patient to easily test his own blood. A prototype is currently being tested in Bangladesh.

Beacon
The Congestive Heart Failure team built a monitoring device called Beacon that would allow elderly patients with chronic conditions to stay in their homes longer. The device sits in a bedroom and is linked wirelessly to sensors throughout the house. If the sensor determines that the patient is moving less than normal, a light on the top of the main unit will turn yellow--alerting the patient to take her blood pressure, or step on a scale. Sudden weight gain, for example, is a sign that the patient’s condition is worsening. Data will be transmitted to the patient’s doctor, who can then communicate with the patient to see if a change in medications is called for, or if more serious intervention is required.

My Op
This app is designed to help patients who are about to undergo surgery for endometriosis learn about what to expect beforehand without scaring themselves by searching Google for information. Post-operatively, the app helps doctors assess how their recovery is going. The biggest problem, developers say, is that patients with this condition are so accustomed to being in pain that they often don’t recognize the severity of their symptoms after surgery, and thus fail to report them to their physicians until they’ve become acute. The My Op app allows doctors to monitor self-reported symptoms, and either text or have a video chat with patients if symptoms are concerning before they worsen.

The Brady Glove (left), The Tremo Cup (right)
AEON Health’s Parkinson’s disease devices
This group built a web-based platform to assess and manage Parkinson’s symptoms at home, allowing a patient to better control his own condition.

The Tremo Cup, which the patient uses to take medications several times a day, detects tremors, which correlate to how well a medication is controlling symptoms. By monitoring data, doctors can assess how long a medication is working, and if the timing or dose needs to be adjusted. It also allows a patient to see if he can influence the efficacy of the medication by adjusting exercise, food, or sleep.

The Brady Glove has sensors in each finger that allow a doctor to detect Bradykinesia–-the slowness of movement that is a prime indicator of Parkinson’s disease. Neurologists can assess the severity of a patient’s symptoms by asking him to tap his fingers, open and close his fist, and alter the position of his palm--the classic tests for Parkinson’s--then adjust his meds to help control symptoms.

Pressure Free
This team’s goal was to find a way for a patient to track and lower her blood pressure with minimal involvement by a physician. The solution was an app with three integrated devices: 

  • a blood pressure cuff that sends data to a dashboard; 
  • a Fitbit to measure how much the patient moves; and 
  • a container that monitors how many pills are still in the bottle
Forget to take your meds, and the 3-G powered pill bottle will send you a text message reminder without having to sync your device. In addition, the app will allow patients to invite friends to act as motivators, sending messages and videos to encourage compliance. The pill bottle, designed by a company called Adhere Tech, is already in development. 

Epicenter
The Epicenter team tackled the problem of controlling epileptic seizures through diet and biofeedback. The Ketogenic Diet app allows patients to track what they eat, measure the ketones they produce, and report side effects to doctors. A Ketogenic diet--high in fat and proteins, low in carbs--has been shown to be effective in controlling seizures, but is tough to follow. This app builds in recipes and meal suggestions, and encourages compliance by giving the patient a visual record of her progress.
Epilepsy app (left), epilepsy cap and wrist senor (right)

Epicenter also created a seizure tracking tool, where the patient can record seizure triggers, log how long the seizure lasted, and document feelings afterward. The patient’s doctor can analyze the data and intervene where necessary, and a gaming device using a neurofeedback cap that measures brain currents and a wrist sensor that measures galvanic skin response allows patients to influence their condition via biofeedback.